Joaquin L. C. G.
- Country
- Spain
- Department
- Infectious Diseases Department
Research Overview
- Efficacy and Safety of 7 vs 14 Days of Antibiotic Therapy with Meropenem, Aztreonam, and Levofloxacin in Pseudomonas aeruginosa Bacteremia
- Comparative Efficacy of Temocillin Sodium Versus Meropenem and Ertapenem Sodium in Treating Enterobacteriaceae Bacteremia Resistant to Third-Generation Cephalosporins
- Non-Inferiority Trial Comparing 7-Day Versus 14-Day Linezolid and Drug Combination Regimens for Uncomplicated Enterococcal Bacteremia
Data & Insights
Has run more than one trial at 75 of 225 partner sites.
Specializations
Respiratory Infections
Specializes in the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia, with particular emphasis on infections caused by gram-negative bacteria. The investigator's work extends to studying various pneumonia manifestations and their clinical management.
- Hospital-acquired pneumonia (HABP)
- Ventilator-associated pneumonia (VABP)
- Community-acquired pneumonia
Bacterial Infections
Focuses on treating complex bacterial infections, particularly Pseudomonas aeruginosa bacteremia and enterococcal infections. The investigator studies optimized antibiotic treatment durations and strategies for managing resistant bacterial strains.
- Enterobacteriales infections
- P. aeruginosa bacteremia
- E. faecalis and E. faecium infections
Infectious Disease Management
Investigates novel approaches in managing infectious diseases, including COVID-19 and Clostridioides difficile infections. The research encompasses preventive strategies and innovative therapeutic interventions.
- COVID-19 prevention
- C. difficile recurrence prevention
- Antimicrobial resistance
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.